RodolfoGalindoMD

Endocrinology • Miami, FL

Diabetes, Obesity

Associate Professor

Join to view full profile

Dr. Galindo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Galindo's full profile

Already have an account?

Office
1400 NW 10th Ave
Suite 805
Miami, FL 33136
Phone+1 305-243-7500

Summary

Dr. Rodolfo Galindo is an endocrinologist in Miami, Fl and is affiliated with University of Miami and Jackson Memorial Hospital. He received his medical degree from Instituto Superior de Ciencias Médicas de La Habana. He specializes in diabetes and obesity. He is an experienced clinical trialist and international faculty and speaker. Member of international guidelines and organizing committee of international conferences.

Education & Training

Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 2010 - 2013
Instituto Superior de Ciencias Médicas de la HabanaClass of 2005

Certifications & Licensure

FL State Medical License 2022 - 2025
GA State Medical License 2017 - 2022
NY State Medical License 2013 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology and Metabolism
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG) Start of enrollment: 2020 Nov 05
Completed
Not Applicable

Publications & Presentations

PubMed

96 citations
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
David C Klonoff, Jing Wang, David Rodbard, Michael A Kohn, Chengdong Li
Journal of Diabetes Science and Technology. 2023-09-01
1 citations
Should We Stop Glucagon-Like Peptide-1 Receptor Agonists Before Surgical or Endoscopic Procedures? Balancing Limited Evidence With Clinical Judgment.
Guillermo Umpierrez, Francisco J Pasquel, Elizabeth Duggan, Rodolfo J Galindo
Journal of Diabetes Science and Technology. 2024-03-11
43 citations
A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.
Maya Fayfman, Rodolfo J. Galindo, Daniel J. Rubin, Dara L. Mize, Isabel Anzola
Diabetes Care. 2019-03-01

Press Mentions

‘Stunning’ Twincretin Beats Semaglutide for A1c, Weight Reduction in T2DJune 26th, 2021
Unmanaged Diabetes, High Blood Glucose Tied to COVID-19 SeverityJune 26th, 2021
Dexcom CGM Plays Starring Role at 81st Scientific Sessions of the American Diabetes AssociationJune 25th, 2021
Join now to see all

Professional Memberships

Endocrine Society - ENDO
Member